Production (Stage)
PMV Pharmaceuticals, Inc.
PMVP
$0.97
$0.022.11%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 24.19% | -19.63% | -1,485.00% | 92.06% | 3.08% |
| Total Depreciation and Amortization | -5.13% | -89.49% | -0.27% | 2.76% | 0.84% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -86.24% | 482.83% | -35.38% | 43.54% | -10.56% |
| Change in Net Operating Assets | -206.23% | 22.15% | 157.82% | 5.89% | -194.19% |
| Cash from Operations | -9.63% | 1.06% | -953.75% | 90.13% | -33.92% |
| Capital Expenditure | 92.86% | -5,500.00% | 75.00% | 99.33% | -201.52% |
| Sale of Property, Plant, and Equipment | -- | 665.52% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 278.97% | -55.66% | 634.46% | -91.30% | 1,219.20% |
| Cash from Investing | 270.79% | -54.76% | 636.93% | -91.12% | 1,111.05% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -94.19% | -- | -100.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -94.19% | -- | -100.00% | -- | -- |
| Foreign Exchange rate Adjustments | 163.64% | -375.00% | -33.33% | 117.65% | -200.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 219.52% | -3,183.10% | -67.43% | -91.23% | 169.32% |